National Association of Testing Authorities, Australia
Scope of Accreditation
Baker IDI Heart and Diabetes Institute
Site
Baker IDI Heart and Diabetes Institute
Accreditation No.
14984
Site No.
15231
Date of Accreditation
17 Dec 2003
Contact
Availability
Services available to external clients
Supervision
M (Medical Practice)
Scope of Accreditation
Baker IDI Heart and Diabetes Institute
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
23 Jan 2027
Last Activity Date
25 Aug 2022
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Blood | HDL - Quantitation; LDL - Quantitation |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Cholesterol - Total; Triglycerides |
| Urine | Albumin; Albumin/creatinine ratio (ACR); Creatinine; Microalbumin |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
14984
Site No.
15231
Print date
29 Nov 2024
END OF SCOPE